Products - Wound management | Topic | NICE

Showing 3 products

Date | Title

Guidance programme: Technology appraisal guidanceRemove ‘Guidance programme: Technology appraisal guidance’ filter

Beremagene geperpavec for treating skin wounds associated with dystrophic epidermolysis bullosa [ID3959]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
15 July 2026
Allo-APZ2-EB for treating dystrophic and junctional epidermolysis bullosa in people of any age [ID6746]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Allo-APZ2-CVU for treating chronic venous leg ulcers [ID6754]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC